The structure, dynamics and selectivity profile of a NaV1.7 potency-optimised huwentoxin-IV variant
Sassan Rahnama(The University of Queensland), Mehdi Mobli(The University of Queensland), Glenn F. King(The University of Queensland), Richard J. Lewis(AstraZeneca (Netherlands)), Venkatraman Ramanujam(The University of Queensland), Jennifer R. Deuis(The University of Queensland), Lachlan D. Rash(The University of Queensland), Fernanda C. Cardoso(The University of Queensland), Irina Vetter(Centre National de la Recherche Scientifique)
Cited by 45
Related Papers
A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases
|Nature Medicine|2015|2.8k
Methods Used to Evaluate Pain Behaviors in Rodents
|Frontiers in Molecular Neuroscience|2017|1.3k
Therapeutic potential of venom peptides
|Nature Reviews Drug Discovery|2003|786
Pathophysiology of Chemotherapy-Induced Peripheral Neuropathy
|Frontiers in Molecular Neuroscience|2017|654
Conus Venom Peptide Pharmacology
|Pharmacological Reviews|2012|422